{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:21:51Z","timestamp":1787314911733,"version":"build-2736575974"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Heilongjiang Provincial Medical and Health Research Fund","award":["20252020010112"],"award-info":[{"award-number":["20252020010112"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00415-026-13900-3","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T17:04:11Z","timestamp":1780160651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The vicious cycle: unraveling the interplay between \u03b1-synuclein, mitochondrial dysfunction, and neuroinflammation in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"273","author":[{"given":"Yu-lin","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-ge","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0978-8112","authenticated-orcid":false,"given":"Qiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"issue":"1","key":"13900_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","volume":"75","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Bloem BR (2018) The Parkinson pandemic\u2014a call to action. JAMA Neurol 75(1):9\u201310. https:\/\/doi.org\/10.1001\/jamaneurol.2017.3299","journal-title":"JAMA Neurol"},{"issue":"10423","key":"13900_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C (2024) The epidemiology of Parkinson\u2019s disease. Lancet 403(10423):283\u2013292. https:\/\/doi.org\/10.1016\/S0140-6736(23)01419-8","journal-title":"Lancet"},{"issue":"18","key":"13900_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cells11182908","volume":"11","author":"B Ara\u00fajo","year":"2022","unstructured":"Ara\u00fajo B, Caridade-Silva R, Soares-Guedes C, Martins-Macedo J, Gomes ED, Monteiro S, Teixeira FG (2022) Neuroinflammation and Parkinson\u2019s disease-from neurodegeneration to therapeutic opportunities. Cells 11(18):2908. https:\/\/doi.org\/10.3390\/cells11182908","journal-title":"Cells"},{"issue":"4","key":"13900_CR4","doi-asserted-by":"publisher","DOI":"10.1088\/1741-2552\/ade567","volume":"22","author":"M Moshchin","year":"2025","unstructured":"Moshchin M, Schultz RJ, Cheng KP, Osting S, Koeper J, Laluzerne M, Trevathan JK, Brzeczkowski A, Luu CP, Yu JJ, Betzel RF, Lake WB, Hurley SA, Ludwig KA, Suminski AJ (2025) Assessing changes in whole-brain structural connectivity in the unilateral 6-hydroxydopamine rat model of Parkinson\u2019s disease using diffusion imaging and tractography. J Neural Eng 22(4):10.1088\/1741-2552\/ade567","journal-title":"J Neural Eng"},{"issue":"1","key":"13900_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","volume":"18","author":"MT Henrich","year":"2023","unstructured":"Henrich MT, Oertel WH, Surmeier DJ, Geibl FF (2023) Mitochondrial dysfunction in Parkinson\u2019s disease\u2014a key disease hallmark with therapeutic potential. Mol Neurodegener 18(1):83. https:\/\/doi.org\/10.1186\/s13024-023-00676-7","journal-title":"Mol Neurodegener"},{"issue":"4","key":"13900_CR6","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3390\/nu15040943","volume":"15","author":"LK Mischley","year":"2023","unstructured":"Mischley LK, Shankland E, Liu SZ, Bhayana S, Fox DJ, Marcinek DJ (2023) ATP and NAD+ deficiency in Parkinson\u2019s disease. Nutrients 15(4):943. https:\/\/doi.org\/10.3390\/nu15040943","journal-title":"Nutrients"},{"issue":"5","key":"13900_CR7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/jcb.30414","volume":"124","author":"S Bagheri-Mohammadi","year":"2023","unstructured":"Bagheri-Mohammadi S, Farjami M, Suha AJ, Zarch SMA, Najafi S, Esmaeili A (2023) The mitochondrial calcium signaling, regulation, and cellular functions: a novel target for therapeutic medicine in neurological disorders. J Cell Biochem 124(5):635\u2013655. https:\/\/doi.org\/10.1002\/jcb.30414","journal-title":"J Cell Biochem"},{"issue":"20","key":"13900_CR8","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1016\/j.cell.2021.09.007","volume":"184","author":"H Scheiblich","year":"2021","unstructured":"Scheiblich H, Dansokho C, Mercan D, Schmidt SV, Bousset L, Wischhof L, Eikens F, Odainic A, Spitzer J, Griep A, Schwartz S, Bano D, Latz E, Melki R, Heneka MT (2021) Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes. Cell 184(20):5089-5106.e21. https:\/\/doi.org\/10.1016\/j.cell.2021.09.007","journal-title":"Cell"},{"issue":"1","key":"13900_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-019-0335-3","volume":"14","author":"S George","year":"2019","unstructured":"George S, Rey NL, Tyson T, Esquibel C, Meyerdirk L, Schulz E, Pierce S, Burmeister AR, Madaj Z, Steiner JA, Escobar Galvis ML, Brundin L, Brundin P (2019) Microglia affect \u03b1-synuclein cell-to-cell transfer in a mouse model of Parkinson\u2019s disease. Mol Neurodegener 14(1):34. https:\/\/doi.org\/10.1186\/s13024-019-0335-3","journal-title":"Mol Neurodegener"},{"key":"13900_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105028","volume":"144","author":"TI Kam","year":"2020","unstructured":"Kam TI, Hinkle JT, Dawson TM, Dawson VL (2020) Microglia and astrocyte dysfunction in Parkinson\u2019s disease. Neurobiol Dis 144:105028. https:\/\/doi.org\/10.1016\/j.nbd.2020.105028","journal-title":"Neurobiol Dis"},{"key":"13900_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4827","volume":"5","author":"G Fusco","year":"2014","unstructured":"Fusco G, De Simone A, Gopinath T, Vostrikov V, Vendruscolo M, Dobson CM, Veglia G (2014) Direct observation of the three regions in \u03b1-synuclein that determine its membrane-bound behaviour. Nat Commun 5:3827. https:\/\/doi.org\/10.1038\/ncomms4827","journal-title":"Nat Commun"},{"issue":"7","key":"13900_CR12","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2174\/1389203717666160314151706","volume":"18","author":"S Sahay","year":"2017","unstructured":"Sahay S, Ghosh D, Singh PK, Maji SK (2017) Alteration of structure and aggregation of \u03b1-synuclein by familial Parkinson\u2019s disease associated mutations. Curr Protein Pept Sci 18(7):656\u2013676. https:\/\/doi.org\/10.2174\/1389203717666160314151706","journal-title":"Curr Protein Pept Sci"},{"issue":"52","key":"13900_CR13","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1039\/d4cc01591f","volume":"60","author":"W Han","year":"2024","unstructured":"Han W, Wei M, Xu F, Niu Z (2024) Aggregation and phase separation of \u03b1-synuclein in Parkinson\u2019s disease. Chem Commun (Camb) 60(52):6581\u20136590. https:\/\/doi.org\/10.1039\/d4cc01591f","journal-title":"Chem Commun (Camb)"},{"issue":"25","key":"13900_CR14","doi-asserted-by":"publisher","first-page":"22680","DOI":"10.1074\/jbc.M101181200","volume":"276","author":"MS Nielsen","year":"2001","unstructured":"Nielsen MS, Vorum H, Lindersson E, Jensen PH (2001) Ca2+ binding to alpha-synuclein regulates ligand binding and oligomerization. J Biol Chem 276(25):22680\u201322684. https:\/\/doi.org\/10.1074\/jbc.M101181200","journal-title":"J Biol Chem"},{"key":"13900_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2019.101729","volume":"185","author":"V Vasquez","year":"2020","unstructured":"Vasquez V, Mitra J, Wang H, Hegde PM, Rao KS, Hegde ML (2020) A multi-faceted genotoxic network of alpha-synuclein in the nucleus and mitochondria of dopaminergic neurons in Parkinson\u2019s disease: emerging concepts and challenges. Prog Neurobiol 185:101729. https:\/\/doi.org\/10.1016\/j.pneurobio.2019.101729","journal-title":"Prog Neurobiol"},{"issue":"1","key":"13900_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/nan.12298","volume":"42","author":"K Del Tredici","year":"2016","unstructured":"Del Tredici K, Braak H (2016) Review: sporadic Parkinson\u2019s disease: development and distribution of \u03b1-synuclein pathology. Neuropathol Appl Neurobiol 42(1):33\u201350. https:\/\/doi.org\/10.1111\/nan.12298","journal-title":"Neuropathol Appl Neurobiol"},{"key":"13900_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tins.2022.11.007","volume":"46","author":"M Sharma","year":"2023","unstructured":"Sharma M, Burr\u00e9 J (2023) \u03b1-Synuclein in synaptic function and dysfunction. Trends Neurosci 46:153\u2013166. https:\/\/doi.org\/10.1016\/j.tins.2022.11.007","journal-title":"Trends Neurosci"},{"issue":"9","key":"13900_CR18","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1523\/JNEUROSCI.20-09-03214.2000","volume":"20","author":"DD Murphy","year":"2000","unstructured":"Murphy DD, Rueter SM, Trojanowski JQ, Lee VM (2000) Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci 20(9):3214\u20133220. https:\/\/doi.org\/10.1523\/JNEUROSCI.20-09-03214.2000","journal-title":"J Neurosci"},{"issue":"10","key":"13900_CR19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2012171118","volume":"118","author":"P Kumari","year":"2021","unstructured":"Kumari P, Ghosh D, Vanas A, Fleischmann Y, Wiegand T, Jeschke G, Riek R, Eichmann C (2021) Structural insights into \u03b1-synuclein monomer-fibril interactions. Proc Natl Acad Sci U S A 118(10):e2012171118. https:\/\/doi.org\/10.1073\/pnas.2012171118","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"13900_CR20","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm VM, Zhang B, O\u2019Brien P, Trojanowski JQ, Lee VM (2012) Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in mice. J Exp Med 209(5):975\u2013986. https:\/\/doi.org\/10.1084\/jem.20112457","journal-title":"J Exp Med"},{"issue":"8","key":"13900_CR21","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41557-020-0465-9","volume":"12","author":"S Ray","year":"2020","unstructured":"Ray S et al (2020) \u03b1-Synuclein aggregation nucleates through liquid-liquid phase separation. Nat Chem 12(8):705\u2013716. https:\/\/doi.org\/10.1038\/s41557-020-0465-9","journal-title":"Nat Chem"},{"issue":"1","key":"13900_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41531-022-00423-7","volume":"8","author":"GS Virdi","year":"2022","unstructured":"Virdi GS et al (2022) Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson\u2019s disease in midbrain dopaminergic neurons. npj Parkinsons Dis 8(1):162. https:\/\/doi.org\/10.1038\/s41531-022-00423-7","journal-title":"npj Parkinsons Dis"},{"key":"13900_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2014.00042","volume":"7","author":"S Tenreiro","year":"2014","unstructured":"Tenreiro S, Eckermann K, Outeiro TF (2014) Protein phosphorylation in neurodegeneration: friend or foe? Front Mol Neurosci 7:42. https:\/\/doi.org\/10.3389\/fnmol.2014.00042","journal-title":"Front Mol Neurosci"},{"key":"13900_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mito.2023.05.007","volume":"71","author":"T Alqahtani","year":"2023","unstructured":"Alqahtani T et al (2023) Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease, and Parkinson\u2019s disease, Huntington\u2019s disease and amyotrophic lateral sclerosis\u2014an updated review. Mitochondrion 71:83\u201392. https:\/\/doi.org\/10.1016\/j.mito.2023.05.007","journal-title":"Mitochondrion"},{"issue":"22","key":"13900_CR25","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1016\/j.neuron.2023.10.030","volume":"111","author":"F Bassil","year":"2023","unstructured":"Bassil F, Brown HJ, Pattabhiraman S, Iwasyk JE, Maghames CM, Meymand ES, Cox TO, Riddle DM, Zhang B, Trojanowski JQ, Lee VM (2023) Amyloid-beta (A\u03b2) plaques promote seeding and spreading of alpha-synuclein and tau in a mouse model of Lewy body disorders with A\u03b2 pathology. Neuron 111(22):3699. https:\/\/doi.org\/10.1016\/j.neuron.2023.10.030","journal-title":"Neuron"},{"issue":"10","key":"13900_CR26","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1093\/brain\/awac171","volume":"145","author":"L Pan","year":"2022","unstructured":"Pan L, Li C, Meng L, Tian Y, He M, Yuan X, Zhang G, Zhang Z, Xiong J, Chen G, Zhang Z (2022) Tau accelerates \u03b1-synuclein aggregation and spreading in Parkinson\u2019s disease. Brain 145(10):3454\u20133471. https:\/\/doi.org\/10.1093\/brain\/awac171","journal-title":"Brain"},{"issue":"44","key":"13900_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj1092","volume":"9","author":"L Meng","year":"2023","unstructured":"Meng L, Liu C, Li Y, Chen G, Xiong M, Yu T, Pan L, Zhang X, Zhou L, Guo T, Yuan X, Liu C, Zhang Z, Zhang Z (2023) The yeast prion protein Sup35 initiates \u03b1-synuclein pathology in mouse models of Parkinson\u2019s disease. Sci Adv 9(44):eadj1092. https:\/\/doi.org\/10.1126\/sciadv.adj1092","journal-title":"Sci Adv"},{"issue":"3","key":"13900_CR28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.neuron.2016.01.026","volume":"89","author":"DW Sanders","year":"2016","unstructured":"Sanders DW, Kaufman SK, Holmes BB, Diamond MI (2016) Prions and protein assemblies that convey biological information in health and disease. Neuron 89(3):433\u2013448. https:\/\/doi.org\/10.1016\/j.neuron.2016.01.026","journal-title":"Neuron"},{"issue":"31","key":"13900_CR29","doi-asserted-by":"publisher","first-page":"13010","DOI":"10.1073\/pnas.0903691106","volume":"106","author":"P Desplats","year":"2009","unstructured":"Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, Spencer B, Masliah E, Lee SJ (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A 106(31):13010\u201313015. https:\/\/doi.org\/10.1073\/pnas.0903691106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"13900_CR30","doi-asserted-by":"publisher","first-page":"707","DOI":"10.5455\/OVJ.2021.v11.i4.23","volume":"11","author":"MJ Gallardo","year":"2021","unstructured":"Gallardo MJ, Delgado FO (2021) Animal prion diseases: a review of intraspecies transmission. Open Vet J 11(4):707\u2013723. https:\/\/doi.org\/10.5455\/OVJ.2021.v11.i4.23","journal-title":"Open Vet J"},{"issue":"11","key":"13900_CR31","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a023630","volume":"8","author":"H Braak","year":"2016","unstructured":"Braak H, Del Tredici K (2016) Potential pathways of abnormal tau and \u03b1-synuclein dissemination in sporadic Alzheimer\u2019s and Parkinson\u2019s diseases. Cold Spring Harb Perspect Biol 8(11):a023630. https:\/\/doi.org\/10.1101\/cshperspect.a023630","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"5","key":"13900_CR32","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1080\/19336896.2016.1223003","volume":"10","author":"S Abounit","year":"2016","unstructured":"Abounit S, Wu JW, Duff K, Victoria GS, Zurzolo C (2016) Tunneling nanotubes: a possible highway in the spreading of tau and other prion-like proteins in neurodegenerative diseases. Prion 10(5):344\u2013351. https:\/\/doi.org\/10.1080\/19336896.2016.1223003","journal-title":"Prion"},{"issue":"19","key":"13900_CR33","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.15252\/embj.201593411","volume":"35","author":"S Abounit","year":"2016","unstructured":"Abounit S, Bousset L, Loria F, Zhu S, de Chaumont F, Pieri L, Olivo-Marin JC, Melki R, Zurzolo C (2016) Tunneling nanotubes spread fibrillar \u03b1-synuclein by intercellular trafficking of lysosomes. EMBO J 35(19):2120\u20132138. https:\/\/doi.org\/10.15252\/embj.201593411","journal-title":"EMBO J"},{"issue":"49","key":"13900_CR34","doi-asserted-by":"publisher","first-page":"11835","DOI":"10.1523\/JNEUROSCI.0983-17.2017","volume":"37","author":"J Rostami","year":"2017","unstructured":"Rostami J, Holmqvist S, Lindstr\u00f6m V, Sigvardson J, Westermark GT, Ingelsson M, Bergstr\u00f6m J, Roybon L, Erlandsson A (2017) Human astrocytes transfer aggregated alpha-synuclein via tunneling nanotubes. J Neurosci 37(49):11835\u201311853. https:\/\/doi.org\/10.1523\/JNEUROSCI.0983-17.2017","journal-title":"J Neurosci"},{"issue":"6","key":"13900_CR35","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/ana.24648","volume":"79","author":"MG Stokholm","year":"2016","unstructured":"Stokholm MG, Danielsen EH, Hamilton-Dutoit SJ, Borghammer P (2016) Pathological \u03b1-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients. Ann Neurol 79(6):940\u2013949. https:\/\/doi.org\/10.1002\/ana.24648","journal-title":"Ann Neurol"},{"issue":"1","key":"13900_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13024-019-0331-7","volume":"14","author":"N Uemura","year":"2019","unstructured":"Uemura N, Yagi H, Uemura MT, Hatanaka Y, Yamakado H, Takahashi R (2019) Inoculation of \u03b1-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve. Mol Neurodegener 14(1):31. https:\/\/doi.org\/10.1186\/s13024-019-0331-7","journal-title":"Mol Neurodegener"},{"issue":"21","key":"13900_CR37","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1212\/WNL.0000000000003961","volume":"88","author":"B Liu","year":"2017","unstructured":"Liu B, Fang F, Pedersen NL, Tillander A, Ludvigsson JF, Ekbom A, Svenningsson P, Chen H, Wirdefeldt K (2017) Vagotomy and Parkinson disease: a Swedish register-based matched-cohort study. Neurology 88(21):1996\u20132002. https:\/\/doi.org\/10.1212\/WNL.0000000000003961","journal-title":"Neurology"},{"issue":"9","key":"13900_CR38","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1242\/dmm.026294","volume":"10","author":"VM Pozo Devoto","year":"2017","unstructured":"Pozo Devoto VM, Falzone TL (2017) Mitochondrial dynamics in Parkinson\u2019s disease: a role for \u03b1-synuclein? Dis Model Mech 10(9):1075\u20131087. https:\/\/doi.org\/10.1242\/dmm.026294","journal-title":"Dis Model Mech"},{"issue":"1","key":"13900_CR39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12951-025-03258-5","volume":"23","author":"S Zhang","year":"2025","unstructured":"Zhang S, Li M, Li Y, Yang S, Wang J, Ren X, Wang X, Bai L, Huang J, Geng Z, Han G, Fang Y, Su J (2025) Mitochondria-targeted nanovesicles for ursodeoxycholic acid delivery to combat neurodegeneration by ameliorating mitochondrial dysfunction. J Nanobiotechnology 23(1):202. https:\/\/doi.org\/10.1186\/s12951-025-03258-5","journal-title":"J Nanobiotechnology"},{"issue":"7886","key":"13900_CR40","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","volume":"599","author":"P Gonz\u00e1lez-Rodr\u00edguez","year":"2021","unstructured":"Gonz\u00e1lez-Rodr\u00edguez P et al (2021) Disruption of mitochondrial complex I induces progressive parkinsonism. Nature 599(7886):650\u2013656. https:\/\/doi.org\/10.1038\/s41586-021-04059-0","journal-title":"Nature"},{"issue":"6","key":"13900_CR41","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ana.410260606","volume":"26","author":"WD Parker Jr","year":"1989","unstructured":"Parker WD Jr, Boyson SJ, Parks JK (1989) Abnormalities of the electron transport chain in idiopathic Parkinson\u2019s disease. Ann Neurol 26(6):719\u2013723. https:\/\/doi.org\/10.1002\/ana.410260606","journal-title":"Ann Neurol"},{"key":"13900_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103047","volume":"70","author":"C Tabata Fukushima","year":"2024","unstructured":"Tabata Fukushima C, Dancil IS, Clary H, Shah N, Nadtochiy SM, Brookes PS (2024) Reactive oxygen species generation by reverse electron transfer at mitochondrial complex I under simulated early reperfusion conditions. Redox Biol 70:103047. https:\/\/doi.org\/10.1016\/j.redox.2024.103047","journal-title":"Redox Biol"},{"issue":"8","key":"13900_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134087","volume":"10","author":"X Su","year":"2015","unstructured":"Su X, Chu Y, Kordower JH, Li B, Cao H, Huang L, Nishida M, Song L, Wang D, Federoff HJ (2015) PGC-1\u03b1 promoter methylation in Parkinson\u2019s disease. PLoS ONE 10(8):e0134087. https:\/\/doi.org\/10.1371\/journal.pone.0134087","journal-title":"PLoS ONE"},{"issue":"711","key":"13900_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo1557","volume":"15","author":"R Qi","year":"2023","unstructured":"Qi R et al (2023) A blood-based marker of mitochondrial DNA damage in Parkinson\u2019s disease. Sci Transl Med 15(711):eabo1557. https:\/\/doi.org\/10.1126\/scitranslmed.abo1557","journal-title":"Sci Transl Med"},{"key":"13900_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2025.102493","volume":"94","author":"C K\u00fcng","year":"2025","unstructured":"K\u00fcng C, Lazarou M, Nguyen TN (2025) Advances in mitophagy initiation mechanisms. Curr Opin Cell Biol 94:102493. https:\/\/doi.org\/10.1016\/j.ceb.2025.102493","journal-title":"Curr Opin Cell Biol"},{"issue":"9","key":"13900_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1372","volume":"9","author":"T Huang","year":"2019","unstructured":"Huang T, Gao CY, Wu L, Gong PY, Wang JZ, Tian YY, Zhang YD (2019) Han Chinese family with early-onset Parkinson\u2019s disease carries novel compound heterozygous mutations in the PARK2 gene. Brain Behav 9(9):e01372. https:\/\/doi.org\/10.1002\/brb3.1372","journal-title":"Brain Behav"},{"issue":"23","key":"13900_CR47","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1212\/WNL.0000000000002744","volume":"86","author":"M Takanashi","year":"2016","unstructured":"Takanashi M, Li Y, Hattori N (2016) Absence of Lewy pathology associated with PINK1 homozygous mutation. Neurology 86(23):2212\u20132213. https:\/\/doi.org\/10.1212\/WNL.0000000000002744","journal-title":"Neurology"},{"issue":"11","key":"13900_CR48","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/mds.27193","volume":"32","author":"SA Schneider","year":"2017","unstructured":"Schneider SA, Alcalay RN (2017) Neuropathology of genetic synucleinopathies with parkinsonism: review of the literature. Mov Disord 32(11):1504\u20131523. https:\/\/doi.org\/10.1002\/mds.27193","journal-title":"Mov Disord"},{"issue":"Pt 4","key":"13900_CR49","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awq051","volume":"133","author":"L Samaranch","year":"2010","unstructured":"Samaranch L, Lorenzo-Betancor O, Arbelo JM, Ferrer I, Lorenzo E, Irigoyen J, Pastor MA, Marrero C, Isla C, Herrera-Henriquez J, Pastor P (2010) PINK1-linked parkinsonism is associated with Lewy body pathology. Brain 133(Pt 4):1128\u20131142. https:\/\/doi.org\/10.1093\/brain\/awq051","journal-title":"Brain"},{"key":"13900_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.nbd.2012.05.015","volume":"51","author":"VS Van Laar","year":"2013","unstructured":"Van Laar VS, Berman SB (2013) The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for Parkinson\u2019s disease. Neurobiol Dis 51:43\u201355. https:\/\/doi.org\/10.1016\/j.nbd.2012.05.015","journal-title":"Neurobiol Dis"},{"issue":"5604","key":"13900_CR51","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/science.1077209","volume":"299","author":"V Bonifati","year":"2003","unstructured":"Bonifati V et al (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299(5604):256\u2013259. https:\/\/doi.org\/10.1126\/science.1077209","journal-title":"Science"},{"issue":"29","key":"13900_CR52","doi-asserted-by":"publisher","first-page":"17296","DOI":"10.1073\/pnas.1922184117","volume":"117","author":"APT Nguyen","year":"2020","unstructured":"Nguyen APT, Tsika E, Kelly K, Levine N, Chen X, West AB, Boularand S, Barneoud P, Moore DJ (2020) Dopaminergic neurodegeneration induced by Parkinson\u2019s disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity. Proc Natl Acad Sci U S A 117(29):17296\u201317307. https:\/\/doi.org\/10.1073\/pnas.1922184117","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"13900_CR53","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/hmg\/ddz004","volume":"28","author":"F Bonello","year":"2019","unstructured":"Bonello F, Hassoun SM, Mouton-Liger F, Shin YS, Muscat A, Tesson C, Lesage S, Beart PM, Brice A, Krupp J, Corvol JC, Corti O (2019) LRRK2 impairs PINK1\/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson\u2019s disease. Hum Mol Genet 28(10):1645\u20131660. https:\/\/doi.org\/10.1093\/hmg\/ddz004","journal-title":"Hum Mol Genet"},{"issue":"2","key":"13900_CR54","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/jnc.14253","volume":"144","author":"S Joseph","year":"2018","unstructured":"Joseph S, Schulz JB, Stegm\u00fcller J (2018) Mechanistic contributions of FBXO7 to Parkinson disease. J Neurochem 144(2):118\u2013127. https:\/\/doi.org\/10.1111\/jnc.14253","journal-title":"J Neurochem"},{"key":"13900_CR55","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-pathmechdis-012419-032711","volume":"15","author":"DC Chan","year":"2020","unstructured":"Chan DC (2020) Mitochondrial dynamics and its involvement in disease. Annu Rev Pathol 15:235\u2013259. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-012419-032711","journal-title":"Annu Rev Pathol"},{"key":"13900_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114282","volume":"182","author":"T Rodrigues","year":"2020","unstructured":"Rodrigues T, Ferraz LS (2020) Therapeutic potential of targeting mitochondrial dynamics in cancer. Biochem Pharmacol 182:114282. https:\/\/doi.org\/10.1016\/j.bcp.2020.114282","journal-title":"Biochem Pharmacol"},{"key":"13900_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2020.138192","volume":"725","author":"BH Zhou","year":"2020","unstructured":"Zhou BH, Wei SS, Jia LS, Zhang Y, Miao CY, Wang HW (2020) Drp1\/Mff signaling pathway is involved in fluoride-induced abnormal fission of hepatocyte mitochondria in mice. Sci Total Environ 725:138192. https:\/\/doi.org\/10.1016\/j.scitotenv.2020.138192","journal-title":"Sci Total Environ"},{"issue":"9","key":"13900_CR58","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/hmg\/ddaa077","volume":"29","author":"YT Liu","year":"2020","unstructured":"Liu YT, Huang X, Nguyen D, Shammas MK, Wu BP, Dombi E, Springer DA, Poulton J, Sekine S, Narendra DP (2020) Loss of CHCHD2 and CHCHD10 activates OMA1 peptidase to disrupt mitochondrial cristae phenocopying patient mutations. Hum Mol Genet 29(9):1547\u20131567. https:\/\/doi.org\/10.1093\/hmg\/ddaa077","journal-title":"Hum Mol Genet"},{"issue":"7","key":"13900_CR59","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1093\/hmg\/ddaa028","volume":"29","author":"T Cornelissen","year":"2020","unstructured":"Cornelissen T, Spinazzi M, Martin S, Imberechts D, Vangheluwe P, Bird M, De Strooper B, Vandenberghe W (2020) CHCHD2 harboring Parkinson\u2019s disease-linked T61I mutation precipitates inside mitochondria and induces precipitation of wild-type CHCHD2. Hum Mol Genet 29(7):1096\u20131106. https:\/\/doi.org\/10.1093\/hmg\/ddaa028","journal-title":"Hum Mol Genet"},{"key":"13900_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15500","volume":"8","author":"H Meng","year":"2017","unstructured":"Meng H, Yamashita C, Shiba-Fukushima K, Inoshita T, Funayama M, Sato S, Hatta T, Natsume T, Umitsu M, Takagi J, Imai Y, Hattori N (2017) Loss of Parkinson\u2019s disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c. Nat Commun 8:15500. https:\/\/doi.org\/10.1038\/ncomms15500","journal-title":"Nat Commun"},{"issue":"1","key":"13900_CR61","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm.3983","volume":"22","author":"W Wang","year":"2016","unstructured":"Wang W, Wang X, Fujioka H, Hoppel C, Whone AL, Caldwell MA, Cullen PJ, Liu J, Zhu X (2016) Parkinson\u2019s disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes. Nat Med 22(1):54\u201363. https:\/\/doi.org\/10.1038\/nm.3983","journal-title":"Nat Med"},{"issue":"3","key":"13900_CR62","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ajhg.2016.01.014","volume":"98","author":"S Lesage","year":"2016","unstructured":"Lesage S et al (2016) Loss of VPS13C function in autosomal-recessive parkinsonism causes mitochondrial dysfunction and increases PINK1\/parkin-dependent mitophagy. Am J Hum Genet 98(3):500\u2013513. https:\/\/doi.org\/10.1016\/j.ajhg.2016.01.014","journal-title":"Am J Hum Genet"},{"key":"13900_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122651","volume":"347","author":"V Rahi","year":"2024","unstructured":"Rahi V, Kaundal RK (2024) Exploring the intricacies of calcium dysregulation in ischemic stroke: insights into neuronal cell death and therapeutic strategies. Life Sci 347:122651. https:\/\/doi.org\/10.1016\/j.lfs.2024.122651","journal-title":"Life Sci"},{"issue":"15","key":"13900_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/cells13151301","volume":"13","author":"G Bastioli","year":"2024","unstructured":"Bastioli G, Piccirillo S, Graciotti L, Carone M, Sprega G, Taoussi O, Preziuso A, Castaldo P (2024) Calcium deregulation in neurodegeneration and neuroinflammation in Parkinson\u2019s disease: role of calcium-storing organelles and sodium-calcium exchanger. Cells 13(15):1301. https:\/\/doi.org\/10.3390\/cells13151301","journal-title":"Cells"},{"issue":"1","key":"13900_CR65","doi-asserted-by":"publisher","first-page":"28","DOI":"10.22088\/cjim.11.1.28","volume":"11","author":"S Samavarchi Tehrani","year":"2020","unstructured":"Samavarchi Tehrani S, Sarfi M, Yousefi T, Ahmadi Ahangar A, Gholinia H, Mohseni Ahangar R, Maniati M, Saadat P (2020) Comparison of the calcium-related factors in Parkinson\u2019s disease patients with healthy individuals. Caspian J Intern Med 11(1):28\u201333. https:\/\/doi.org\/10.22088\/cjim.11.1.28","journal-title":"Caspian J Intern Med"},{"issue":"10","key":"13900_CR66","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1093\/brain\/awaf051","volume":"148","author":"A Chemla","year":"2025","unstructured":"Chemla A et al (2025) Parkinson\u2019s disease mutant Miro1 causes mitochondrial dysfunction and dopaminergic neuron loss. Brain 148(10):3607\u20133622. https:\/\/doi.org\/10.1093\/brain\/awaf051","journal-title":"Brain"},{"key":"13900_CR67","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-pharmtox-010818-021214","volume":"59","author":"B Liss","year":"2019","unstructured":"Liss B, Striessnig J (2019) The potential of L-type calcium channels as a drug target for neuroprotective therapy in Parkinson\u2019s disease. Annu Rev Pharmacol Toxicol 59:263\u2013289. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010818-021214","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"13900_CR68","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00441-014-1936-3","volume":"357","author":"SM Berger","year":"2014","unstructured":"Berger SM, Bartsch D (2014) The role of L-type voltage-gated calcium channels Cav1.2 and Cav1.3 in normal and pathological brain function. Cell Tissue Res 357(2):463\u2013476. https:\/\/doi.org\/10.1007\/s00441-014-1936-3","journal-title":"Cell Tissue Res"},{"issue":"34","key":"13900_CR69","doi-asserted-by":"publisher","first-page":"30232","DOI":"10.1074\/jbc.M111.240358","volume":"286","author":"G Samak","year":"2011","unstructured":"Samak G, Narayanan D, Jaggar JH, Rao R (2011) CaV1.3 channels and intracellular calcium mediate osmotic stress-induced N-terminal c-Jun kinase activation and disruption of tight junctions in Caco-2 cell monolayers. J Biol Chem 286(34):30232\u201330243. https:\/\/doi.org\/10.1074\/jbc.M111.240358","journal-title":"J Biol Chem"},{"issue":"7","key":"13900_CR70","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.4103\/1673-5374.387986","volume":"19","author":"N Prakash","year":"2024","unstructured":"Prakash N (2024) A dysregulated calcium homeostasis as the earliest pathological sign in stem cell-derived Parkinson\u2019s disease neurons? Neural Regen Res 19(7):1421\u20131422. https:\/\/doi.org\/10.4103\/1673-5374.387986","journal-title":"Neural Regen Res"},{"issue":"1","key":"13900_CR71","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/s41467-017-01435-1","volume":"8","author":"E Huang","year":"2017","unstructured":"Huang E, Qu D, Huang T, Rizzi N, Boonying W, Krolak D, Ciana P, Woulfe J, Klein C, Slack RS, Figeys D, Park DS (2017) PINK1-mediated phosphorylation of LETM1 regulates mitochondrial calcium transport and protects neurons against mitochondrial stress. Nat Commun 8(1):1399. https:\/\/doi.org\/10.1038\/s41467-017-01435-1","journal-title":"Nat Commun"},{"issue":"1","key":"13900_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32551-7","volume":"8","author":"A Matteucci","year":"2018","unstructured":"Matteucci A, Patron M, Vecellio Reane D, Gastaldello S, Amoroso S, Rizzuto R, Brini M, Raffaello A, Cal\u00ec T (2018) Parkin-dependent regulation of the MCU complex component MICU1. Sci Rep 8(1):14199. https:\/\/doi.org\/10.1038\/s41598-018-32551-7","journal-title":"Sci Rep"},{"issue":"4","key":"13900_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1469-5","volume":"10","author":"MHR Ludtmann","year":"2019","unstructured":"Ludtmann MHR, Kostic M, Horne A, Gandhi S, Sekler I, Abramov AY (2019) LRRK2 deficiency induced mitochondrial Ca2+ efflux inhibition can be rescued by Na+\/Ca2+\/Li+ exchanger upregulation. Cell Death Dis 10(4):265. https:\/\/doi.org\/10.1038\/s41419-019-1469-5","journal-title":"Cell Death Dis"},{"issue":"1","key":"13900_CR74","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12943-024-02172-y","volume":"23","author":"R He","year":"2024","unstructured":"He R, Liu Y, Fu W, He X, Liu S, Xiao D, Tao Y (2024) Mechanisms and cross-talk of regulated cell death and their epigenetic modifications in tumor progression. Mol Cancer 23(1):267. https:\/\/doi.org\/10.1186\/s12943-024-02172-y","journal-title":"Mol Cancer"},{"issue":"4","key":"13900_CR75","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s10571-022-01265-w","volume":"43","author":"M Abrishamdar","year":"2023","unstructured":"Abrishamdar M, Jalali MS, Farbood Y (2023) Targeting mitochondria as a therapeutic approach for Parkinson\u2019s disease. Cell Mol Neurobiol 43(4):1499\u20131518. https:\/\/doi.org\/10.1007\/s10571-022-01265-w","journal-title":"Cell Mol Neurobiol"},{"key":"13900_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102838","volume":"111","author":"FG Yang","year":"2025","unstructured":"Yang FG, Liang YL, Wang X, Wang JT, Gao W, Ye QY, Li XY, Yang Y, Li HL (2025) The evolution of Alzheimer\u2019s disease: from mitochondria to microglia. Ageing Res Rev 111:102838. https:\/\/doi.org\/10.1016\/j.arr.2025.102838","journal-title":"Ageing Res Rev"},{"key":"13900_CR77","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4528616","volume":"2019","author":"X Li","year":"2019","unstructured":"Li X, Fang F, Gao Y, Tang G, Xu W, Wang Y, Kong R, Tuyihong A, Wang Z (2019) ROS induced by KillerRed targeting mitochondria (mtKR) enhances apoptosis caused by radiation via Cyt c\/caspase-3 pathway. Oxid Med Cell Longev 2019:4528616. https:\/\/doi.org\/10.1155\/2019\/4528616","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"13900_CR78","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1021\/acschemneuro.8b00356","volume":"10","author":"J Liu","year":"2019","unstructured":"Liu J, Liu W, Yang H (2019) Balancing apoptosis and autophagy for Parkinson\u2019s disease therapy: targeting BCL-2. ACS Chem Neurosci 10(2):792\u2013802. https:\/\/doi.org\/10.1021\/acschemneuro.8b00356","journal-title":"ACS Chem Neurosci"},{"issue":"9","key":"13900_CR79","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202153234","volume":"23","author":"L Qu","year":"2022","unstructured":"Qu L, Lin B, Zeng W, Fan C, Wu H, Ge Y, Li Q, Li C, Wei Y, Xin J, Wang X, Liu D, Cang C (2022) Lysosomal K+ channel TMEM175 promotes apoptosis and aggravates symptoms of Parkinson\u2019s disease. EMBO Rep 23(9):e53234. https:\/\/doi.org\/10.15252\/embr.202153234","journal-title":"EMBO Rep"},{"issue":"6","key":"13900_CR80","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13031","volume":"18","author":"BG Trist","year":"2019","unstructured":"Trist BG, Hare DJ, Double KL (2019) Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease. Aging Cell 18(6):e13031. https:\/\/doi.org\/10.1111\/acel.13031","journal-title":"Aging Cell"},{"issue":"767","key":"13900_CR81","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adl3438","volume":"16","author":"MT Keeney","year":"2024","unstructured":"Keeney MT et al (2024) LRRK2 regulates production of reactive oxygen species in cell and animal models of Parkinson\u2019s disease. Sci Transl Med 16(767):eadl3438. https:\/\/doi.org\/10.1126\/scitranslmed.adl3438","journal-title":"Sci Transl Med"},{"issue":"2","key":"13900_CR82","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100875","volume":"39","author":"T Toyofuku","year":"2020","unstructured":"Toyofuku T, Okamoto Y, Ishikawa T, Sasawatari S, Kumanogoh A (2020) LRRK2 regulates endoplasmic reticulum-mitochondrial tethering through the PERK-mediated ubiquitination pathway. EMBO J 39(2):e100875. https:\/\/doi.org\/10.15252\/embj.2018100875","journal-title":"EMBO J"},{"issue":"9","key":"13900_CR83","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1093\/hmg\/dds003","volume":"21","author":"X Wang","year":"2012","unstructured":"Wang X, Yan MH, Fujioka H, Liu J, Wilson-Delfosse A, Chen SG, Perry G, Casadesus G, Zhu X (2012) LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum Mol Genet 21(9):1931\u20131944. https:\/\/doi.org\/10.1093\/hmg\/dds003","journal-title":"Hum Mol Genet"},{"key":"13900_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2025.103141","volume":"95","author":"G Cogan","year":"2025","unstructured":"Cogan G, Lesage S, Brice A (2025) The genetics of autosomal recessive early-onset Parkinson\u2019s disease. Curr Opin Neurobiol 95:103141. https:\/\/doi.org\/10.1016\/j.conb.2025.103141","journal-title":"Curr Opin Neurobiol"},{"issue":"6357","key":"13900_CR85","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","volume":"357","author":"LF Burbulla","year":"2017","unstructured":"Burbulla LF et al (2017) Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease. Science 357(6357):1255\u20131261. https:\/\/doi.org\/10.1126\/science.aam9080","journal-title":"Science"},{"issue":"24","key":"13900_CR86","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1021\/acschemneuro.3c00717","volume":"14","author":"D Shukla","year":"2023","unstructured":"Shukla D et al (2023) Glutathione depletion and concomitant elevation of susceptibility in patients with Parkinson\u2019s disease: state-of-the-art MR spectroscopy and neuropsychological study. ACS Chem Neurosci 14(24):4383\u20134394. https:\/\/doi.org\/10.1021\/acschemneuro.3c00717","journal-title":"ACS Chem Neurosci"},{"issue":"25","key":"13900_CR87","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1016\/j.cell.2025.11.002","volume":"188","author":"Y Wang","year":"2025","unstructured":"Wang Y et al (2025) Innate immune and metabolic signals induce mitochondria-dependent membrane lysis via mitoxyperiosis. Cell 188(25):7155-7174.e25. https:\/\/doi.org\/10.1016\/j.cell.2025.11.002","journal-title":"Cell"},{"issue":"s1","key":"13900_CR88","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.3233\/JPD-213138","volume":"12","author":"J Garc\u00eda-Revilla","year":"2022","unstructured":"Garc\u00eda-Revilla J, Herrera AJ, de Pablos RM, Venero JL (2022) Inflammatory animal models of Parkinson\u2019s disease. J Parkinsons Dis 12(s1):S165\u2013S182. https:\/\/doi.org\/10.3233\/JPD-213138","journal-title":"J Parkinsons Dis"},{"issue":"9","key":"13900_CR89","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/nm.4397","volume":"23","author":"MW Salter","year":"2017","unstructured":"Salter MW, Stevens B (2017) Microglia emerge as central players in brain disease. Nat Med 23(9):1018\u20131027. https:\/\/doi.org\/10.1038\/nm.4397","journal-title":"Nat Med"},{"issue":"8","key":"13900_CR90","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/wnl.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 38(8):1285\u20131291. https:\/\/doi.org\/10.1212\/wnl.38.8.1285","journal-title":"Neurology"},{"issue":"5","key":"13900_CR91","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrg3413","volume":"14","author":"JL Ronan","year":"2013","unstructured":"Ronan JL, Wu W, Crabtree GR (2013) From neural development to cognition: unexpected roles for chromatin. Nat Rev Genet 14(5):347\u2013359. https:\/\/doi.org\/10.1038\/nrg3413","journal-title":"Nat Rev Genet"},{"key":"13900_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1390310","volume":"16","author":"Q Liu","year":"2024","unstructured":"Liu Q, Liu Z, Xie W, Li Y, Wang H, Zhang S, Wang W, Hao J, Geng D, Yang J, Wang L (2024) Single-cell sequencing of the substantia nigra reveals microglial activation in a model of MPTP. Front Aging Neurosci 16:1390310. https:\/\/doi.org\/10.3389\/fnagi.2024.1390310","journal-title":"Front Aging Neurosci"},{"key":"13900_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104870","volume":"140","author":"E Abati","year":"2020","unstructured":"Abati E, Citterio G, Bresolin N, Comi GP, Corti S (2020) Glial cells involvement in spinal muscular atrophy: Could SMA be a neuroinflammatory disease? Neurobiol Dis 140:104870. https:\/\/doi.org\/10.1016\/j.nbd.2020.104870","journal-title":"Neurobiol Dis"},{"issue":"8","key":"13900_CR94","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3390\/cells8080776","volume":"8","author":"L Acu\u00f1a","year":"2019","unstructured":"Acu\u00f1a L, Hamadat S, Corbal\u00e1n NS, Gonz\u00e1lez-Liz\u00e1rraga F, Dos-Santos-Pereira M, Rocca J, D\u00edaz JS, Del-Bel E, Papy-Garc\u00eda D, Cheh\u00edn RN, Michel PP, Raisman-Vozari R (2019) Rifampicin and its derivative rifampicin quinone reduce microglial inflammatory responses and neurodegeneration induced in vitro by \u03b1-synuclein fibrillary aggregates. Cells 8(8):776. https:\/\/doi.org\/10.3390\/cells8080776","journal-title":"Cells"},{"issue":"7","key":"13900_CR95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3002712","volume":"22","author":"K Bohmbach","year":"2024","unstructured":"Bohmbach K, Henneberger C (2024) Activity-induced reactivity of astrocytes impairs cognition. PLoS Biol 22(7):e3002712. https:\/\/doi.org\/10.1371\/journal.pbio.3002712","journal-title":"PLoS Biol"},{"issue":"45","key":"13900_CR96","doi-asserted-by":"publisher","first-page":"7463","DOI":"10.1523\/JNEUROSCI.1376-23.2023","volume":"43","author":"D Barnett","year":"2023","unstructured":"Barnett D, Bohmbach K, Grelot V, Charlet A, Dall\u00e9rac G, Ju YH, Nagai J, Orr AG (2023) Astrocytes as drivers and disruptors of behavior: new advances in basic mechanisms and therapeutic targeting. J Neurosci 43(45):7463\u20137471. https:\/\/doi.org\/10.1523\/JNEUROSCI.1376-23.2023","journal-title":"J Neurosci"},{"issue":"3","key":"13900_CR97","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00401-007-0244-3","volume":"114","author":"H Braak","year":"2007","unstructured":"Braak H, Sastre M, Del Tredici K (2007) Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson\u2019s disease. Acta Neuropathol 114(3):231\u2013241. https:\/\/doi.org\/10.1007\/s00401-007-0244-3","journal-title":"Acta Neuropathol"},{"issue":"7638","key":"13900_CR98","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA et al (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541(7638):481\u2013487. https:\/\/doi.org\/10.1038\/nature21029","journal-title":"Nature"},{"issue":"1","key":"13900_CR99","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/imr.13121","volume":"311","author":"BC Smith","year":"2022","unstructured":"Smith BC, Tinkey RA, Shaw BC, Williams JL (2022) Targetability of the neurovascular unit in inflammatory diseases of the central nervous system. Immunol Rev 311(1):39\u201349. https:\/\/doi.org\/10.1111\/imr.13121","journal-title":"Immunol Rev"},{"issue":"3","key":"13900_CR100","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/glia.22437","volume":"61","author":"L Fellner","year":"2013","unstructured":"Fellner L, Irschick R, Schanda K, Reindl M, Klimaschewski L, Poewe W, Wenning GK, Stefanova N (2013) Toll-like receptor 4 is required for \u03b1-synuclein dependent activation of microglia and astroglia. Glia 61(3):349\u2013360. https:\/\/doi.org\/10.1002\/glia.22437","journal-title":"Glia"},{"issue":"1","key":"13900_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44732-2","volume":"15","author":"G Morrone Parfitt","year":"2024","unstructured":"Morrone Parfitt G, Coccia E, Goldman C, Whitney K, Reyes R, Sarrafha L, Nam KH, Sohail S, Jones DR, Crary JF, Ordureau A, Blanchard J, Ahfeldt T (2024) Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson\u2019s disease model. Nat Commun 15(1):447. https:\/\/doi.org\/10.1038\/s41467-024-44732-2","journal-title":"Nat Commun"},{"issue":"1","key":"13900_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-025-03462-y","volume":"22","author":"F Lind-Holm Mogensen","year":"2025","unstructured":"Lind-Holm Mogensen F, Seibler P, Gr\u00fcnewald A, Michelucci A (2025) Microglial dynamics and neuroinflammation in prodromal and early Parkinson\u2019s disease. J Neuroinflammation 22(1):136. https:\/\/doi.org\/10.1186\/s12974-025-03462-y","journal-title":"J Neuroinflammation"},{"issue":"1","key":"13900_CR103","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41531-023-00626-6","volume":"10","author":"SC Pike","year":"2024","unstructured":"Pike SC, Havrda M, Gilli F, Zhang Z, Salas LA (2024) Immunological shifts during early-stage Parkinson\u2019s disease identified with DNA methylation data on longitudinally collected blood samples. npj Park Dis 10(1):21. https:\/\/doi.org\/10.1038\/s41531-023-00626-6","journal-title":"npj Park Dis"},{"issue":"6","key":"13900_CR104","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","volume":"16","author":"EK Tan","year":"2020","unstructured":"Tan EK, Chao YX, West A, Chan LL, Poewe W, Jankovic J (2020) Parkinson disease and the immune system - associations, mechanisms and therapeutics. Nat Rev Neurol 16(6):303\u2013318. https:\/\/doi.org\/10.1038\/s41582-020-0344-4","journal-title":"Nat Rev Neurol"},{"issue":"1-2","key":"13900_CR105","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jneuroim.2012.07.015","volume":"252","author":"CH Stevens","year":"2012","unstructured":"Stevens CH, Rowe D, Morel-Kopp MC, Orr C, Russell T, Ranola M, Ward C, Halliday GM (2012) Reduced T helper and B lymphocytes in Parkinson\u2019s disease. J Neuroimmunol 252(1\u20132):95\u201399. https:\/\/doi.org\/10.1016\/j.jneuroim.2012.07.015","journal-title":"J Neuroimmunol"},{"key":"13900_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.01081","volume":"9","author":"JB Schr\u00f6der","year":"2018","unstructured":"Schr\u00f6der JB, Pawlowski M, Meyer Zu H\u00f6rste G, Gross CC, Wiendl H, Meuth SG, Ruck T, Warnecke T (2018) Immune cell activation in the cerebrospinal fluid of patients with Parkinson\u2019s disease. Front Neurol 9:1081. https:\/\/doi.org\/10.3389\/fneur.2018.01081","journal-title":"Front Neurol"},{"key":"13900_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4633","volume":"5","author":"C Cebri\u00e1n","year":"2014","unstructured":"Cebri\u00e1n C, Zucca FA, Mauri P, Steinbeck JA, Studer L, Scherzer CR, Kanter E, Budhu S, Mandelbaum J, Vonsattel JP, Zecca L, Loike JD, Sulzer D (2014) MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration. Nat Commun 5:3633. https:\/\/doi.org\/10.1038\/ncomms4633","journal-title":"Nat Commun"},{"issue":"2","key":"13900_CR108","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cell.2016.05.039","volume":"166","author":"D Matheoud","year":"2016","unstructured":"Matheoud D et al (2016) Parkinson\u2019s disease-related proteins PINK1 and parkin repress mitochondrial antigen presentation. Cell 166(2):314\u2013327. https:\/\/doi.org\/10.1016\/j.cell.2016.05.039","journal-title":"Cell"},{"key":"13900_CR109","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuint.2018.07.003","volume":"120","author":"R Niranjan","year":"2018","unstructured":"Niranjan R (2018) Recent advances in the mechanisms of neuroinflammation and their roles in neurodegeneration. Neurochem Int 120:13\u201320. https:\/\/doi.org\/10.1016\/j.neuint.2018.07.003","journal-title":"Neurochem Int"},{"issue":"1","key":"13900_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-022-00839-6","volume":"29","author":"SJ Chen","year":"2022","unstructured":"Chen SJ, Lin CH (2022) Gut microenvironmental changes as a potential trigger in Parkinson\u2019s disease through the gut-brain axis. J Biomed Sci 29(1):54. https:\/\/doi.org\/10.1186\/s12929-022-00839-6","journal-title":"J Biomed Sci"},{"issue":"1","key":"13900_CR111","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-026-00542-8","volume":"15","author":"Z Liu","year":"2026","unstructured":"Liu Z, Nie J, Li Y, Huang M, Chen Z, Yu S, Zheng J, Tan Y, Chen S (2026) Bacteroides coprocola protects dopaminergic neurons in rotenone-induced Parkinson\u2019s disease mouse model by modulating gut microbiota dysbiosis and inhibiting the NLRP3 signaling pathway. Transl Neurodegener 15(1):7. https:\/\/doi.org\/10.1186\/s40035-026-00542-8","journal-title":"Transl Neurodegener"},{"issue":"1","key":"13900_CR112","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1523\/JNEUROSCI.2507-13.2014","volume":"34","author":"C Guardia-Laguarta","year":"2014","unstructured":"Guardia-Laguarta C, Area-Gomez E, R\u00fcb C, Liu Y, Magran\u00e9 J, Becker D, Voos W, Schon EA, Przedborski S (2014) \u03b1-Synuclein is localized to mitochondria-associated ER membranes. J Neurosci 34(1):249\u2013259. https:\/\/doi.org\/10.1523\/JNEUROSCI.2507-13.2014","journal-title":"J Neurosci"},{"key":"13900_CR113","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fnins.2018.00388","volume":"12","author":"M Vicario","year":"2018","unstructured":"Vicario M, Cieri D, Brini M, Cal\u00ec T (2018) The close encounter between alpha-synuclein and mitochondria. Front Neurosci 12:388. https:\/\/doi.org\/10.3389\/fnins.2018.00388","journal-title":"Front Neurosci"},{"issue":"8","key":"13900_CR114","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1021\/acschemneuro.9b00320","volume":"10","author":"S Ghio","year":"2019","unstructured":"Ghio S, Camilleri A, Caruana M, Ruf VC, Schmidt F, Leonov A, Ryazanov S, Griesinger C, Cauchi RJ, Kamp F, Giese A, Vassallo N (2019) Cardiolipin promotes pore-forming activity of alpha-synuclein oligomers in mitochondrial membranes. ACS Chem Neurosci 10(8):3815\u20133829. https:\/\/doi.org\/10.1021\/acschemneuro.9b00320","journal-title":"ACS Chem Neurosci"},{"issue":"342","key":"13900_CR115","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf3634","volume":"8","author":"R Di Maio","year":"2016","unstructured":"Di Maio R, Barrett PJ, Hoffman EK, Barrett CW, Zharikov A, Borah A, Hu X, McCoy J, Chu CT, Burton EA, Hastings TG, Greenamyre JT (2016) \u03b1-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson\u2019s disease. Sci Transl Med 8(342):342ra78. https:\/\/doi.org\/10.1126\/scitranslmed.aaf3634","journal-title":"Sci Transl Med"},{"issue":"20","key":"13900_CR116","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1038\/emboj.2010.223","volume":"29","author":"F Kamp","year":"2010","unstructured":"Kamp F, Exner N, Lutz AK, Wender N, Hegermann J, Brunner B, Nuscher B, Bartels T, Giese A, Beyer K, Eimer S, Winklhofer KF, Haass C (2010) Inhibition of mitochondrial fusion by \u03b1-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J 29(20):3571\u20133589. https:\/\/doi.org\/10.1038\/emboj.2010.223","journal-title":"EMBO J"},{"issue":"1","key":"13900_CR117","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1038\/s41467-018-04422-2","volume":"9","author":"MHR Ludtmann","year":"2018","unstructured":"Ludtmann MHR et al (2018) \u03b1-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson\u2019s disease. Nat Commun 9(1):2293. https:\/\/doi.org\/10.1038\/s41467-018-04422-2","journal-title":"Nat Commun"},{"issue":"8","key":"13900_CR118","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.febslet.2010.03.012","volume":"584","author":"K Banerjee","year":"2010","unstructured":"Banerjee K, Sinha M, Pham Cle L, Jana S, Chanda D, Cappai R, Chakrabarti S (2010) Alpha-synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: implications in Parkinson\u2019s disease. FEBS Lett 584(8):1571\u20131576. https:\/\/doi.org\/10.1016\/j.febslet.2010.03.012","journal-title":"FEBS Lett"},{"key":"13900_CR119","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3390\/cells12040651","volume":"12","author":"PY\u00d8 Nielsen","year":"2023","unstructured":"Nielsen PY\u00d8, Okarmus J, Meyer M (2023) Role of deubiquitinases in Parkinson\u2019s disease-therapeutic perspectives. Cells 12:651. https:\/\/doi.org\/10.3390\/cells12040651","journal-title":"Cells"},{"issue":"3","key":"13900_CR120","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0165-1781(79)90006-4","volume":"1","author":"GC Davis","year":"1979","unstructured":"Davis GC, Williams AC, Markey SP, Ebert MH, Caine ED, Reichert CM, Kopin IJ (1979) Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res 1(3):249\u2013254. https:\/\/doi.org\/10.1016\/0165-1781(79)90006-4","journal-title":"Psychiatry Res"},{"issue":"3","key":"13900_CR121","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3892\/mmr.2022.12607","volume":"25","author":"J Zhang","year":"2022","unstructured":"Zhang J, Sun B, Yang J, Chen Z, Li Z, Zhang N, Li H, Shen L (2022) Comparison of the effect of rotenone and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on inducing chronic Parkinson\u2019s disease in mouse models. Mol Med Rep 25(3):91. https:\/\/doi.org\/10.3892\/mmr.2022.12607","journal-title":"Mol Med Rep"},{"issue":"1","key":"13900_CR122","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s40478-024-01915-8","volume":"12","author":"A Jishi","year":"2024","unstructured":"Jishi A, Hu D, Shang Y, Wang R, Gunzler SA, Qi X (2024) BCKDK loss impairs mitochondrial Complex I activity and drives alpha-synuclein aggregation in models of Parkinson\u2019s disease. Acta Neuropathol Commun 12(1):198. https:\/\/doi.org\/10.1186\/s40478-024-01915-8","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"13900_CR123","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3390\/biom12050655","volume":"12","author":"C Chavarr\u00eda","year":"2022","unstructured":"Chavarr\u00eda C, Ivagnes R, Souza JM (2022) Extracellular alpha-synuclein: mechanisms for glial cell internalization and activation. Biomolecules 12(5):655. https:\/\/doi.org\/10.3390\/biom12050655","journal-title":"Biomolecules"},{"key":"13900_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2534","volume":"4","author":"C Kim","year":"2013","unstructured":"Kim C, Ho DH, Suk JE, You S, Michael S, Kang J, Joong Lee S, Masliah E, Hwang D, Lee HJ, Lee SJ (2013) Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat Commun 4:1562. https:\/\/doi.org\/10.1038\/ncomms2534","journal-title":"Nat Commun"},{"issue":"41","key":"13900_CR125","doi-asserted-by":"publisher","first-page":"31002","DOI":"10.1074\/jbc.M602794200","volume":"281","author":"M Triantafilou","year":"2006","unstructured":"Triantafilou M, Gamper FG, Haston RM, Mouratis MA, Morath S, Hartung T, Triantafilou K (2006) Membrane sorting of toll-like receptor (TLR)-2\/6 and TLR2\/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J Biol Chem 281(41):31002\u201331011. https:\/\/doi.org\/10.1074\/jbc.M602794200","journal-title":"J Biol Chem"},{"key":"13900_CR126","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.719807","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Xia Y, Yin S, Wan F, Hu J, Kou L, Sun Y, Wu J, Zhou Q, Huang J, Xiong N, Wang T (2021) Targeting microglial \u03b1-synuclein\/TLRs\/NF-kappaB\/NLRP3 inflammasome axis in Parkinson\u2019s disease. Front Immunol 12:719807. https:\/\/doi.org\/10.3389\/fimmu.2021.719807","journal-title":"Front Immunol"},{"key":"13900_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.666737","volume":"12","author":"AN MacMahon Copas","year":"2021","unstructured":"MacMahon Copas AN, McComish SF, Fletcher JM, Caldwell MA (2021) The pathogenesis of Parkinson\u2019s disease: a complex interplay between astrocytes, microglia, and T lymphocytes? Front Neurol 12:666737. https:\/\/doi.org\/10.3389\/fneur.2021.666737","journal-title":"Front Neurol"},{"issue":"1","key":"13900_CR128","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00401-024-02696-z","volume":"147","author":"YC Wu","year":"2024","unstructured":"Wu YC, Bogale TA, Koistinaho J, Pizzi M, Rolova T, Bellucci A (2024) The contribution of \u03b2-amyloid, Tau and \u03b1-synuclein to blood-brain barrier damage in neurodegenerative disorders. Acta Neuropathol 147(1):39. https:\/\/doi.org\/10.1007\/s00401-024-02696-z","journal-title":"Acta Neuropathol"},{"issue":"1","key":"13900_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01776-7","volume":"17","author":"J Rostami","year":"2020","unstructured":"Rostami J, Fotaki G, Sirois J, Mzezewa R, Bergstr\u00f6m J, Essand M, Healy L, Erlandsson A (2020) Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson\u2019s disease brain. J Neuroinflammation 17(1):119. https:\/\/doi.org\/10.1186\/s12974-020-01776-7","journal-title":"J Neuroinflammation"},{"issue":"1","key":"13900_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-021-00263-x","volume":"8","author":"C Pellegrini","year":"2022","unstructured":"Pellegrini C, D\u2019Antongiovanni V, Miraglia F, Rota L, Benvenuti L, Di Salvo C, Testa G, Capsoni S, Carta G, Antonioli L, Cattaneo A, Blandizzi C, Colla E, Fornai M (2022) Enteric \u03b1-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson\u2019s disease before brain pathology. NPJ Park Dis 8(1):9. https:\/\/doi.org\/10.1038\/s41531-021-00263-x","journal-title":"NPJ Park Dis"},{"issue":"9","key":"13900_CR131","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.3748\/wjg.v12.i9.1392","volume":"12","author":"YP Zhang","year":"2006","unstructured":"Zhang YP, Yao XX, Zhao X (2006) Interleukin-1 beta up-regulates tissue inhibitor of matrix metalloproteinase-1 mRNA and phosphorylation of c-jun N-terminal kinase and p38 in hepatic stellate cells. World J Gastroenterol 12(9):1392\u20131396. https:\/\/doi.org\/10.3748\/wjg.v12.i9.1392","journal-title":"World J Gastroenterol"},{"issue":"4","key":"13900_CR132","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040820","volume":"9","author":"L Hoffmeister","year":"2020","unstructured":"Hoffmeister L, Diekmann M, Brand K, Huber R (2020) GSK3: a kinase balancing promotion and resolution of inflammation. Cells 9(4):820. https:\/\/doi.org\/10.3390\/cells9040820","journal-title":"Cells"},{"issue":"5","key":"13900_CR133","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/cdd.2014.179","volume":"22","author":"JJ Credle","year":"2015","unstructured":"Credle JJ, George JL, Wills J, Duka V, Shah K, Lee YC, Rodriguez O, Simkins T, Winter M, Moechars D, Steckler T, Goudreau J, Finkelstein DI, Sidhu A (2015) GSK-3\u03b2 dysregulation contributes to Parkinson\u2019s-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and \u03b1-synuclein. Cell Death Differ 22(5):838\u2013851. https:\/\/doi.org\/10.1038\/cdd.2014.179","journal-title":"Cell Death Differ"},{"issue":"4","key":"13900_CR134","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1177\/19476035231194771","volume":"15","author":"W Xu","year":"2024","unstructured":"Xu W, Wang J, Cui L, Huang C, Xia N, Xie M, Liu D, Liao D (2024) Il-1\u03b2 promotes superficial zone cells senescence in articular cartilage by inhibiting autophagy. Cartilage 15(4):428\u2013439. https:\/\/doi.org\/10.1177\/19476035231194771","journal-title":"Cartilage"},{"issue":"9","key":"13900_CR135","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1359\/jbmr.2000.15.9.1669","volume":"15","author":"R Tonon","year":"2000","unstructured":"Tonon R, D\u2019Andrea P (2000) Interleukin-1beta increases the functional expression of connexin 43 in articular chondrocytes: evidence for a Ca2+-dependent mechanism. J Bone Miner Res 15(9):1669\u20131677. https:\/\/doi.org\/10.1359\/jbmr.2000.15.9.1669","journal-title":"J Bone Miner Res"},{"issue":"2","key":"13900_CR136","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055068","volume":"8","author":"K Nakaso","year":"2013","unstructured":"Nakaso K, Tajima N, Ito S, Teraoka M, Yamashita A, Horikoshi Y, Kikuchi D, Mochida S, Nakashima K, Matsura T (2013) Dopamine-mediated oxidation of methionine 127 in \u03b1-synuclein causes cytotoxicity and oligomerization of \u03b1-synuclein. PLoS ONE 8(2):e55068. https:\/\/doi.org\/10.1371\/journal.pone.0055068","journal-title":"PLoS ONE"},{"issue":"1","key":"13900_CR137","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12035-018-1082-0","volume":"56","author":"A Wilkaniec","year":"2019","unstructured":"Wilkaniec A, Lenkiewicz AM, Czapski GA, J\u0119\u015bko HM, Hilgier W, Brodzik R, G\u0105ssowska-Dobrowolska M, Culmsee C, Adamczyk A (2019) Extracellular alpha-synuclein oligomers induce parkin S-nitrosylation: relevance to sporadic Parkinson\u2019s disease etiopathology. Mol Neurobiol 56(1):125\u2013140. https:\/\/doi.org\/10.1007\/s12035-018-1082-0","journal-title":"Mol Neurobiol"},{"issue":"17","key":"13900_CR138","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1089\/ars.2015.6407","volume":"23","author":"K Nakahira","year":"2015","unstructured":"Nakahira K, Hisata S, Choi AM (2015) The roles of mitochondrial damage-associated molecular patterns in diseases. Antioxid Redox Signal 23(17):1329\u20131350. https:\/\/doi.org\/10.1089\/ars.2015.6407","journal-title":"Antioxid Redox Signal"},{"issue":"9","key":"13900_CR139","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1038\/s12276-024-01295-y","volume":"56","author":"S Chung","year":"2024","unstructured":"Chung S, Jeong JH, Park JC, Han JW, Lee Y, Kim JI, Mook-Jung I (2024) Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u2019s disease pathologies. Exp Mol Med 56(9):1936\u20131951. https:\/\/doi.org\/10.1038\/s12276-024-01295-y","journal-title":"Exp Mol Med"},{"key":"13900_CR140","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nrd2059","volume":"5","author":"AM Krieg","year":"2006","unstructured":"Krieg AM (2006) Therapeutic potential of toll-like receptor 9 activation. Nat Rev Drug Discov 5:471\u2013484. https:\/\/doi.org\/10.1038\/nrd2059","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"13900_CR141","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.immuni.2013.08.001","volume":"39","author":"SS Iyer","year":"2013","unstructured":"Iyer SS et al (2013) Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity 39(2):311\u2013323. https:\/\/doi.org\/10.1016\/j.immuni.2013.08.001","journal-title":"Immunity"},{"issue":"1","key":"13900_CR142","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13410","volume":"329","author":"S Gupta","year":"2025","unstructured":"Gupta S, Cassel SL, Sutterwala FS, Dagvadorj J (2025) Regulation of the NLRP3 inflammasome by autophagy and mitophagy. Immunol Rev 329(1):e13410. https:\/\/doi.org\/10.1111\/imr.13410","journal-title":"Immunol Rev"},{"issue":"3","key":"13900_CR143","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.bbadis.2014.11.019","volume":"1852","author":"P Prajapati","year":"2015","unstructured":"Prajapati P, Sripada L, Singh K, Bhatelia K, Singh R, Singh R (2015) TNF-\u03b1 regulates miRNA targeting mitochondrial complex-I and induces cell death in dopaminergic cells. Biochim Biophys Acta 1852(3):451\u2013461. https:\/\/doi.org\/10.1016\/j.bbadis.2014.11.019","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"13900_CR144","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.niox.2005.07.010","volume":"13","author":"LL Pearce","year":"2005","unstructured":"Pearce LL, Kanai AJ, Epperly MW, Peterson J (2005) Nitrosative stress results in irreversible inhibition of purified mitochondrial complexes I and III without modification of cofactors. Nitric Oxide 13(4):254\u2013263. https:\/\/doi.org\/10.1016\/j.niox.2005.07.010","journal-title":"Nitric Oxide"},{"key":"13900_CR145","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adn8699","volume":"17","author":"LL Bao","year":"2025","unstructured":"Bao LL et al (2025) Epithelial OPA1 links mitochondrial fusion to inflammatory bowel disease. Sci Transl Med 17:eadn8699. https:\/\/doi.org\/10.1126\/scitranslmed.adn8699","journal-title":"Sci Transl Med"},{"issue":"3","key":"13900_CR146","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/path.6081","volume":"260","author":"JM Fenimore","year":"2023","unstructured":"Fenimore JM, Springer DA, Romero ME, Edmondson EF, McVicar DW, Yanpallewar S, Sanford M, Spindel T, Engle E, Meyer TJ, Valencia JC, Young HA (2023) IFN-\u03b3 and androgens disrupt mitochondrial function in murine myocytes. J Pathol 260(3):276\u2013288. https:\/\/doi.org\/10.1002\/path.6081","journal-title":"J Pathol"},{"issue":"4","key":"13900_CR147","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.3892\/ijmm.2018.3385","volume":"41","author":"YL Shen","year":"2018","unstructured":"Shen YL, Shi YZ, Chen GG, Wang LL, Zheng MZ, Jin HF, Chen YY (2018) TNF-\u03b1 induces Drp1-mediated mitochondrial fragmentation during inflammatory cardiomyocyte injury. Int J Mol Med 41(4):2317\u20132327. https:\/\/doi.org\/10.3892\/ijmm.2018.3385","journal-title":"Int J Mol Med"},{"issue":"7","key":"13900_CR148","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41419-024-06826-z","volume":"15","author":"T Li","year":"2024","unstructured":"Li T, Qu J, Hu C, Pang J, Qian Y, Li Y, Peng Z (2024) Macrophage migration inhibitory factor (MIF) suppresses mitophagy through disturbing the protein interaction of PINK1-Parkin in sepsis-associated acute kidney injury. Cell Death Dis 15(7):473. https:\/\/doi.org\/10.1038\/s41419-024-06826-z","journal-title":"Cell Death Dis"},{"key":"13900_CR149","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41419-024-06534-8","volume":"15","author":"JA Parmasad","year":"2024","unstructured":"Parmasad JA et al (2024) Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy. Cell Death Dis 15:246. https:\/\/doi.org\/10.1038\/s41419-024-06534-8","journal-title":"Cell Death Dis"},{"key":"13900_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105218","volume":"148","author":"J Yang","year":"2021","unstructured":"Yang J, Luo S, Zhang J, Yu T, Fu Z, Zheng Y, Xu X, Liu C, Fan M, Zhang Z (2021) Exosome-mediated delivery of antisense oligonucleotides targeting \u03b1-synuclein ameliorates the pathology in a mouse model of Parkinson\u2019s disease. Neurobiol Dis 148:105218. https:\/\/doi.org\/10.1016\/j.nbd.2020.105218","journal-title":"Neurobiol Dis"},{"issue":"29","key":"13900_CR151","doi-asserted-by":"publisher","first-page":"7693","DOI":"10.1523\/JNEUROSCI.0628-16.2016","volume":"36","author":"JR Mazzulli","year":"2016","unstructured":"Mazzulli JR, Zunke F, Tsunemi T, Toker NJ, Jeon S, Burbulla LF, Patnaik S, Sidransky E, Marugan JJ, Sue CM, Krainc D (2016) Activation of \u03b2-glucocerebrosidase reduces pathological \u03b1-Synuclein and restores lysosomal function in Parkinson\u2019s patient midbrain neurons. J Neurosci 36(29):7693\u20137706. https:\/\/doi.org\/10.1523\/JNEUROSCI.0628-16.2016","journal-title":"J Neurosci"},{"issue":"4","key":"13900_CR152","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1007\/s13311-021-01130-6","volume":"18","author":"J Zhang","year":"2021","unstructured":"Zhang J, Zhao M, Yan R, Liu J, Maddila S, Junn E, Mouradian MM (2021) MicroRNA-7 protects against neurodegeneration induced by \u03b1-synuclein preformed fibrils in the mouse brain. Neurotherapeutics 18(4):2529\u20132540. https:\/\/doi.org\/10.1007\/s13311-021-01130-6","journal-title":"Neurotherapeutics"},{"issue":"12","key":"13900_CR153","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1002\/pmic.200400848","volume":"4","author":"M Basso","year":"2004","unstructured":"Basso M, Giraudo S, Corpillo D, Bergamasco B, Lopiano L, Fasano M (2004) Proteome analysis of human substantia nigra in Parkinson\u2019s disease. Proteomics 4(12):3943\u20133952. https:\/\/doi.org\/10.1002\/pmic.200400848","journal-title":"Proteomics"},{"issue":"6","key":"13900_CR154","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21062230","volume":"21","author":"Y Yabuki","year":"2020","unstructured":"Yabuki Y, Matsuo K, Kawahata I, Fukui N, Mizobata T, Kawata Y, Owada Y, Shioda N, Fukunaga K (2020) Fatty acid binding protein 3 enhances the spreading and toxicity of \u03b1-synuclein in mouse brain. Int J Mol Sci 21(6):2230. https:\/\/doi.org\/10.3390\/ijms21062230","journal-title":"Int J Mol Sci"},{"issue":"8","key":"13900_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114546","volume":"43","author":"D Dutta","year":"2024","unstructured":"Dutta D, Paidi RK, Raha S, Roy A, Chandra S, Pahan K (2024) Treadmill exercise reduces \u03b1-synuclein spreading via PPAR\u03b1. Cell Rep 43(8):114546. https:\/\/doi.org\/10.1016\/j.celrep.2024.114546","journal-title":"Cell Rep"},{"issue":"6","key":"13900_CR156","doi-asserted-by":"publisher","DOI":"10.3390\/nu12061707","volume":"12","author":"CY Huang","year":"2020","unstructured":"Huang CY, Sivalingam K, Shibu MA, Liao PH, Ho TJ, Kuo WW, Chen RJ, Day CH, Viswanadha VP, Ju DT (2020) Induction of autophagy by vasicinone protects neural cells from mitochondrial dysfunction and attenuates paraquat-mediated Parkinson\u2019s disease associated \u03b1-synuclein levels. Nutrients 12(6):1707. https:\/\/doi.org\/10.3390\/nu12061707","journal-title":"Nutrients"},{"issue":"17","key":"13900_CR157","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411235","volume":"12","author":"Y Xi","year":"2025","unstructured":"Xi Y, Tao K, Wen X, Feng D, Mai Z, Ding H, Mao H, Wang M, Yang Q, Xiang J, Zhang J, Wu S (2025) SIRT3-mediated deacetylation of DRP1K711 prevents mitochondrial dysfunction in Parkinson\u2019s disease. Adv Sci 12(17):e2411235. https:\/\/doi.org\/10.1002\/advs.202411235","journal-title":"Adv Sci"},{"issue":"6","key":"13900_CR158","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.1007\/s12035-017-0712-2","volume":"55","author":"D Tucker","year":"2018","unstructured":"Tucker D, Lu Y, Zhang Q (2018) From mitochondrial function to neuroprotection-an emerging role for methylene blue. Mol Neurobiol 55(6):5137\u20135153. https:\/\/doi.org\/10.1007\/s12035-017-0712-2","journal-title":"Mol Neurobiol"},{"key":"13900_CR159","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.pneurobio.2015.10.005","volume":"157","author":"SH Yang","year":"2017","unstructured":"Yang SH, Li W, Sumien N, Forster M, Simpkins JW, Liu R (2017) Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: methylene blue connects the dots. Prog Neurobiol 157:273\u2013291. https:\/\/doi.org\/10.1016\/j.pneurobio.2015.10.005","journal-title":"Prog Neurobiol"},{"issue":"11\u201312","key":"13900_CR160","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1080\/10715762.2018.1489128","volume":"52","author":"KL Lin","year":"2018","unstructured":"Lin KL, Lin KJ, Wang PW, Chuang JH, Lin HY, Chen SD, Chuang YC, Huang ST, Tiao MM, Chen JB, Huang PH, Liou CW, Lin TK (2018) Resveratrol provides neuroprotective effects through modulation of mitochondrial dynamics and ERK1\/2 regulated autophagy. Free Radic Res 52(11\u201312):1371\u20131386. https:\/\/doi.org\/10.1080\/10715762.2018.1489128","journal-title":"Free Radic Res"},{"issue":"8","key":"13900_CR161","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1007\/s11064-020-03061-8","volume":"45","author":"S Pakrashi","year":"2020","unstructured":"Pakrashi S, Chakraborty J, Bandyopadhyay J (2020) Neuroprotective role of quercetin on rotenone-induced toxicity in SH-SY5Y cell line through modulation of apoptotic and autophagic pathways. Neurochem Res 45(8):1962\u20131973. https:\/\/doi.org\/10.1007\/s11064-020-03061-8","journal-title":"Neurochem Res"},{"issue":"11","key":"13900_CR162","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1016\/j.bbamem.2013.06.026","volume":"1828","author":"A Camilleri","year":"2013","unstructured":"Camilleri A, Zarb C, Caruana M, Ostermeier U, Ghio S, H\u00f6gen T, Schmidt F, Giese A, Vassallo N (2013) Mitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenols. Biochim Biophys Acta 1828(11):2532\u20132543. https:\/\/doi.org\/10.1016\/j.bbamem.2013.06.026","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"13900_CR163","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.4103\/1673-5374.360242","volume":"18","author":"HY Yu","year":"2023","unstructured":"Yu HY, Sun T, Wang Z, Li H, Xu D, An J, Wen LL, Li JY, Li W, Feng J (2023) Exendin-4 and linagliptin attenuate neuroinflammation in a mouse model of Parkinson\u2019s disease. Neural Regen Res 18(8):1818\u20131826. https:\/\/doi.org\/10.4103\/1673-5374.360242","journal-title":"Neural Regen Res"},{"key":"13900_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2022.136669","volume":"781","author":"J Zhang","year":"2022","unstructured":"Zhang J, Wang M, Zhao Y, Zhang Y, Gao Y, Zhang X, Yang G (2022) Alpha-lipoic acid improved motor function in MPTP-induced Parkinsonian mice by reducing neuroinflammation in the nigral and spinal cord. Neurosci Lett 781:136669. https:\/\/doi.org\/10.1016\/j.neulet.2022.136669","journal-title":"Neurosci Lett"},{"key":"13900_CR165","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.lfs.2019.02.037","volume":"223","author":"C Cheng","year":"2019","unstructured":"Cheng C, Zhu X (2019) Cordycepin mitigates MPTP-induced Parkinson\u2019s disease through inhibiting TLR\/NF-\u03baB signaling pathway. Life Sci 223:120\u2013127. https:\/\/doi.org\/10.1016\/j.lfs.2019.02.037","journal-title":"Life Sci"},{"issue":"1","key":"13900_CR166","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13024-025-00818-z","volume":"20","author":"RX Zhu","year":"2025","unstructured":"Zhu RX, Han RX, Chen YH, Huang L, Liu T, Jiang J, Wang C, Cao L, Liu Y, Lu M (2025) Inactivation of NLRP3 inflammasome by dephosphorylation at Serine 658 alleviates glial inflammation in the mouse model of Parkinson\u2019s disease. Mol Neurodegener 20(1):27. https:\/\/doi.org\/10.1186\/s13024-025-00818-z","journal-title":"Mol Neurodegener"},{"key":"13900_CR167","doi-asserted-by":"publisher","DOI":"10.34133\/research.0846","volume":"8","author":"T Meng","year":"2025","unstructured":"Meng T, Zhang Y, Fu S, Ma S (2025) Gpr35 expression mitigates neuroinflammation and enriches gut Lactobacillus to relieve Parkinson\u2019s disease. Research 8:0846. https:\/\/doi.org\/10.34133\/research.0846","journal-title":"Research"},{"issue":"2","key":"13900_CR168","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.apsb.2024.10.011","volume":"15","author":"M Shang","year":"2025","unstructured":"Shang M, Ning J, Zang C, Ma J, Yang Y, Jiang Y, Chen Q, Dong Y, Wang J, Li F, Bao X, Zhang D (2025) FLZ attenuates Parkinson\u2019s disease pathological damage by increasing glycoursodeoxycholic acid production via down-regulating Clostridium innocuum. Acta Pharm Sin B 15(2):973\u2013990. https:\/\/doi.org\/10.1016\/j.apsb.2024.10.011","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"13900_CR169","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-01190-x","volume":"11","author":"C Mu","year":"2025","unstructured":"Mu C, Zhou Z, Li J, Su M, Xue K, Zhang J, Shi S, Li Y, Yao X, Wang M, Zhang W, Wang Z, Zhu J, Fang S, Wang W, Tang C, Qin X (2025) GDNF signaling modulation by Akkermansia muciniphila ameliorates constipation-depression comorbidity in Parkinson\u2019s disease. npj Parkinsons Dis 11(1):342. https:\/\/doi.org\/10.1038\/s41531-025-01190-x","journal-title":"npj Parkinsons Dis"},{"issue":"8","key":"13900_CR170","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.67037","volume":"16","author":"WS Roberts","year":"2024","unstructured":"Roberts WS, Price S, Wu M, Parmar MS (2024) Emerging gene therapies for Alzheimer\u2019s and Parkinson\u2019s diseases: an overview of clinical trials and promising candidates. Cureus 16(8):e67037. https:\/\/doi.org\/10.7759\/cureus.67037","journal-title":"Cureus"},{"issue":"1","key":"13900_CR171","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-024-00770-4","volume":"19","author":"F Xie","year":"2024","unstructured":"Xie F, Shen B, Luo Y, Zhou H, Xie Z, Zhu S, Wei X, Chang Z, Zhu Z, Ding C, Jin K, Yang C, Batzu L, Chaudhuri KR, Chan LL, Tan EK, Wang Q (2024) Repetitive transcranial magnetic stimulation alleviates motor impairment in Parkinson\u2019s disease: association with peripheral inflammatory regulatory T-cells and SYT6. Mol Neurodegener 19(1):80. https:\/\/doi.org\/10.1186\/s13024-024-00770-4","journal-title":"Mol Neurodegener"},{"issue":"9","key":"13900_CR172","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.14670\/HH-18-874","volume":"40","author":"W Wei","year":"2025","unstructured":"Wei W, Wu J, Zhang D, Xu S, Wang Y, Li X, Yu M, Chen X (2025) The synergetic effect of edaravone and scutellarin in the MPP(+)-induced cell model of Parkinson\u2019s disease. Histol Histopathol 40(9):1457\u20131466. https:\/\/doi.org\/10.14670\/HH-18-874","journal-title":"Histol Histopathol"},{"issue":"5\u20136","key":"13900_CR173","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/10799893.2024.2434112","volume":"44","author":"O Kavrik","year":"2024","unstructured":"Kavrik O, Gumral N, Ozmen O, Aslankoc R, Saygin M, Yalcin A (2024) The combined use of thymoquinone and metformin provides more effective neuroprotection in a mouse model of MPTP-induced Parkinson\u2019s disease. J Recept Signal Transduct Res 44(5\u20136):161\u2013173. https:\/\/doi.org\/10.1080\/10799893.2024.2434112","journal-title":"J Recept Signal Transduct Res"},{"issue":"1","key":"13900_CR174","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12906-017-1959-x","volume":"17","author":"TT Zhao","year":"2017","unstructured":"Zhao TT, Kim KS, Shin KS, Park HJ, Kim HJ, Lee KE, Lee MK (2017) Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson\u2019s disease treated with L-DOPA. BMC Complement Altern Med 17(1):449. https:\/\/doi.org\/10.1186\/s12906-017-1959-x","journal-title":"BMC Complement Altern Med"},{"issue":"5","key":"13900_CR175","doi-asserted-by":"publisher","first-page":"523","DOI":"10.4062\/biomolther.2024.075","volume":"32","author":"JH Kim","year":"2024","unstructured":"Kim JH, Kim JS, Ju IG, Huh E, Choi Y, Lee S, Cho JY, Park BY, Oh MS (2024) Coadministration of 6-shogaol and levodopa alleviates Parkinson\u2019s disease-related pathology in mice. Biomol Ther 32(5):523\u2013530. https:\/\/doi.org\/10.4062\/biomolther.2024.075","journal-title":"Biomol Ther"},{"issue":"12","key":"13900_CR176","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.1021\/acs.jmedchem.8b00204","volume":"61","author":"M Jaiteh","year":"2018","unstructured":"Jaiteh M, Zeifman A, Saarinen M, Svenningsson P, Br\u00e9a J, Loza MI, Carlsson J (2018) Docking screens for dual inhibitors of disparate drug targets for Parkinson\u2019s disease. J Med Chem 61(12):5269\u20135278. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b00204","journal-title":"J Med Chem"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13900-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13900-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13900-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T17:10:06Z","timestamp":1781370606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13900-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":176,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["13900"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13900-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this submission. There are no commercial associations, patent applications, or other potential conflicts that might affect the objectivity of this research and application plan. All authors have reviewed this declaration and confirm its accuracy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"350"}}